Related Experiment Video
Updated: Jun 12, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
NSAID-induced Gastric Ulcer Disease: A Deleterious Connection
Hamza Islam1, Areeba Siddiqui2, Rabia Islam1
1Department of Internal Medicine, Punjab Medical College, 38000 Faisalabad, Pakistan.
Non-steroidal anti-inflammatory drug (NSAID) use is a major risk factor for peptic ulcers. This review covers NSAID-induced ulcers, focusing on prevention and management strategies for patients.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Non-steroidal anti-inflammatory drug (NSAID) use is a significant public health concern linked to peptic ulcer pathogenesis.
- Chronic NSAID use is a primary risk factor for peptic ulcers, particularly in patients with comorbidities or on anticoagulant therapy.
Purpose of the Study:
- To review risk factors, pathogenesis, clinical presentation, diagnosis, prevention, and treatment of NSAID-induced peptic ulcers.
- To highlight effective strategies for managing and preventing peptic ulcers in NSAID users.
Main Methods:
- Comprehensive literature review of studies on NSAID-induced peptic ulcers.
- Analysis of diagnostic tests and alternative medications for NSAID toxicity.
Main Results:
- NSAID usage is strongly associated with peptic mucosal erosion.
- Selective cyclooxygenase-2 (COX-2) inhibitors and lowest effective NSAID dosages are recommended for prevention.
Conclusions:
- Effective prevention and management of NSAID-induced ulcers are crucial.
- Utilizing COX-2 inhibitors or minimizing NSAID dosage can mitigate ulcer risk in vulnerable populations.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

